Steven Devine, MD
Chief Medical Officer
Steven Devine, MD, is the Chief Medical Officer for NMDP BioTherapies℠ and NMDP℠. He is responsible for evaluating the science behind cellular therapies and their potential clinical impact, as well helping to determine opportunities to leverage the assets of our organization to partner with cell and gene therapy companies who are bringing therapies to patients.
Dr. Devine also serves as the Associate Scientific Director at the CIBMTR® (Center for International Blood and Marrow Transplant®), providing oversight of the CIBMTR Minneapolis research team, defining strategy and setting direction. In addition, he works to identify, evaluate and acquire new business opportunities for the prospective clinical research program.
Prior to joining NMDP BioTherapies, NMDP and CIBMTR, he was Professor of Internal Medicine and Director of the Blood and Marrow Transplant program at the Ohio State University Comprehensive Cancer Center–Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC-James). Before that, he held positions at Washington University in St. Louis, the University of Illinois in Chicago and Emory University in Atlanta.
Dr. Devine has also served on the graft-versus-host disease advisory boards of Bristol Myers Squibb, Incyte Pharmaceuticals, Kiadis Inc., and Genzyme. He is a past member of the board of directors of the National Cancer Institute (NCI) Alliance for Clinical Trials cooperative group and the American Society of Blood and Marrow Transplantation (now the American Society for Transplantation and Cellular Therapy (ASTCT)).
He is past chair of the National Heart Lung and Blood/NCI-sponsored Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Steering Committee, and of the transplant committee for the Alliance, part of the NCI’s National Clinical Trials Network.
He is a member of the American Society of Hematology, the American Society of Clinical Oncology, the Association for the Advancement of Cancer Research and the ASTCT.
Dr. Devine graduated from the University of Massachusetts Medical School and trained in hematology/oncology at the University of Chicago and Emory University.